nivolumab,bempegaldesleukin
bms,nektar
['nivo', 'bempeg', 'rcc,(-irccs),(-srcc),(-urcc)', 'biomarker', 'marker ']
amazing talk by nizar tanir despite negative results with bempegnivo vs tki in 1l mrcc!we need to learn more from negative trials with biomarker exploration! #esmo22 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine